Fintel on MSN9h
BTIG Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.
BTIG energy/infrastructure analyst holds analyst/industry conference call
Energy & Infrastructure Analyst Lewis and Fixed Income Strategist Malley discuss bitcoin mining trends and themes across the capital ...
What is Roth Capital’s Estimate for Iris Energy Q2 Earnings?
Analysts at Roth Capital lifted their Q2 2025 earnings per share (EPS) estimates for Iris Energy in a research note issued to ...
MoonLake Immunotherapeutics price target raised to $81 from $71 at BTIG
BTIG raised the firm’s price target on MoonLake Immunotherapeutics (MLTX) to $81 from $71 and keeps a Buy rating on the ...
The Armenian Reporter18h
ImmunityBio (NASDAQ:IBRX) Sets New 12-Month Low – Here’s Why
Shares of ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) reached a new 52-week low during trading on Friday . The stock ...
Verona Pharma’s Ohtuvayre: Unique COPD Solution Drives Buy Rating Amid Market Potential and Revenue Growth
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
Reuters14h
United States
U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...
Rugbypass22h
Rugby News
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...